logo
Intelligence
Tracking
Tools
logo
Intelligence
Tracking
Tools

Celegence Acquires Qdossier To Bolster Its Regulatory Consultancy Services And Solutions For The Pharmaceutical Industry

Jul 18, 2022•over 3 years ago

Acquiring Company

Celegence

Acquired Company

Qdossier

Media And EntertainmentSoftwareManufacturingSoftware

Description

Celegence, a global provider of regulatory affairs services and solutions for the life sciences industry, has today announced the acquisition of Qdossier, a supplier of end-to-end services to support document and dossier lifecycle management for pharmaceutical products. Qdossier also provides leading cloud-based technology, which creates transparency, consistency, and reusability across regulatory dossiers.

Company Information

Company

Celegence

About

Celegence helps life sciences companies navigate complex global regulatory requirements by providing consulting services and solutions dedicated to regulatory affairs. Celegence supports life science customers in the areas of EU MDR compliance, IVDR compliance, regulatory intelligence, RIMS data management, publishing, regulatory labeling including UDI consulting, and medical writing. Celegence's depth of experience and extensive delivery capabilities allow regulatory affairs and quality teams to operate more efficiently, reduce cost, and improve compliance. For more information, visit www.celegence.com or follow Celegence on LinkedIn.

M&A Insights

Based on deal data
Integration timeline
70% of M&A integrations take 12-24 months to complete
Tech stack consolidation
83% of merged companies consolidate technology vendors within first year
Post-acquisition investment
Companies increase IT spending by 23% on average after acquisitions
Success factor
M&A deals with strong technology integration plans are 2.5x more likely to succeed